Prevalencia de factores de riesgo cardiovascular, síndrome metabólico e hiperuricemia en personal docente y administrativo de la Facultad de Medicina de la Universidad de El Salvador en el año 2018
Keywords:
Prevalence, Metabolic syndrome, Cardiovascular risk factors, Obesity, Hyperuricemia, Health professionalsAbstract
Cardiovascular disease is a worldwide public health problem. Cardiovascular risk factors (CVRF) have been identified, which may appear isolated, or combined in the definition of “metabolic syndrome” (MetS). The importance of its screening in the adult population is their susceptibility of being modified through health interventions. The aim of this research is to quantify the prevalence of CVDS, MetS and hyperuricemia in the Faculty of Medicine staff. Patients and methods: Cross sectional design for prevalence, inviting all staff to participate, measuring criteria for: CVRF, MetS and hyperuricemia. Results: There were 207 participants: 108 female and 99 males. The most common CVRF was obesity (adding overweight) with 81.8 %, and low High Density Lipoproteins (HDL) levels with 56.45 %. Prevalence of MetS by Adult Treatment Panel (ATP) III was 28.8 % and by JIS 34.78 %. There was a variation of prevalence for men with ATP III (26.26 %) and JIS (38.38 %) dependent on the cutoff point of waist circumference, compared with equal prevalence for women with both definitions (31.48 %). Prevalence for hyperuricemia was 4.8 %. Conclusions: The prevalence of CVRF and MetS are high in the staff population of the Faculty of Medicine University of El Salvador, with a predominance in administrative staff and men
Downloads
References
Health statisticas and information system [Internet]. Ginebra: Wordl Health Organization; 2017 [citado: 21 agosto 2017]. Disponible en: http://www.who.int/healthinfo/global_burden_disease/ estimates/en/ index1.html
Mottillo S, Filion KB, Genest J, Joseph L, Pilote L, Poirier P, et al. The metabolic syndrome and cardiovascular risk. A systematic review and meta-analysis. J Am Coll Cardiol. 2010;56(14):1113-32.
Mahmood SS, Levy D, Ramachandran SV, Wang TJ. The Framingham Heart Study and the epidemiology of cardiovascular diseases: A historical perspective. Lancet. 2014;383(9921):999-1008.
Hurley LP, Dickinson LM, Estacio RO, Steiner JF, Havranek EP. Prediction of cardiovascular death in racial/ethnic minorities using Framingham risk factors. Circ Cardiovasc Qual Outcomes. 2010;3(2): 181-7.
Wilson PWF, D’Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation. 1998;97(18):1837-47.
Friöes F, Azevedo A, Castro A, Alvelos M, Pimenta J, Vasquez B, et al. Impacto dos factores de risco cardiovascular numa amostra da pop- ulação do Porto de acordo com os modelos de predição de risco de Framingham. Rev Port Cardiol. 2003;22(4):511-20.
Orozco-Gonzalez CN, Cortez-Sanabria L, Viera-Franco JJ, Ramirez- Marquez JJ, Cueta-Manzano AM. Prevalencia de factores de riesgo cardiovascular en trabajadores de la salud. Rev Med Inst Mex Seguro Soc. 2016;54(5):594-601.
Risk Function [Internet]. Framingham Heart Study; 2017 [citado: 25 agosto 2017]. Disponible en: https://www.framinghamheartstudy. org/risk-functions/cardiovascular-disease/10-year-risk.php#
Risk Score Calculators [Internet]. Framingham Heart Study; 2017 [citado: 23 agosto 2017]. Disponible en: https://www.framingham heartstudy.org/risk-functions/cardiovascular-disease/ index.php
Risk assesment working group [Internet]. National Heart, Lung, and Blood Institute; 2013 [citado: 24 agosto 2017]. Disponible en: https:// www.nhlbi.nih.gov/sites/www.nhlbi.nih.gov/files/ risk-assessment.pdf
Aschner P, Buendia R, Brajkovich I, Gonzalez A, Figueredo R, Juarez XE, et al. Determination of the cutoff point for waist circumference that establishes the presence of abdominal obesity in Latin American men and women. Diabetes Res Clin Pract. 2011;93(2):243-7.
Alberti GMMK, Zimmet P, Shaw J. Metabolic syndrome—a new world wide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med. 2006;23(5):469-80.
Kassi E, Pervandou P, Kaltsas G, Chrousos G. Metabolic syndrome: definitions and controversies. Biomed Central Medicine. 2011;5(9):48.
Alberti KGMM, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA. Harmonizing the metabolic syndrome. Circulation. 2009;120(16): 1640-5.
Can AS, Bersot TP. Analysis of agreement among definitions of met- abolic syndrome. Biomed Central. 2007; 7:353.
Ford ES, Li C, Sattar N. Metabolic syndrome and incident diabetes. Diabetes Care. 2008;31(9):1898-904.
Dunkley AJ, Charles K, Gray LJ, Camosso-Stefinovic J, Davies MJ, Khunti K. Effectiveness of interventions for reducing diabetes and cardiovascular disease risk in people with metabolic syndrome: systematic review and mixed treatment comparison meta- analysis. Diabetes Obes Metab. 2012;14(7):616-25.
Hosseinpanah F, Borzooei S, Barzin M, Golkashani HA, Azizi F. Prognostic impact of different definitions of metabolic syndrome in predicting cardiovascular events in a cohort of non-diabetic Tehranian adults. Int J Cardiol. 2013;168(1):369-74.
Norris P, Ralph N, Moloney C. Does metabolic syndrome predict sur- gical complications? a protocol for Systematic Review and metaanal- ysis. Biomed Central. 2017;6:115.
Zhao G, Huang L, Song M, Song Y. Baseline serum uric acid levels as a predictor of cardiovascular disease related mortality and all cause mortality. A meta analysis of prospective studies. Atheroesclerosis. 2013;231:61-8.
Xu Q, Zhang M, Abeysekera IR, Wang X. High serum uric acid levels may increase mortality and major adverse cardiovascular events in patients with acute myocardial infarction. Saudi Med J. 2017;38(6): 577-85.
Puddu PE, Belarcea G, Vagnarelli OT, Lombardi C, Mancini M, Zancheki A, et al. Serum uric acid and eGFR_CKDEPI differently predict long term cardiovascular events and all causes of deaths in a residential cohort. Int J Cardiol. 2014;171:361-67.
Kaur J. Comprehensive review on metabolic syndrome. Cardiol Res Pract. 2014;2014:943162.
Rubinstein AL, Irazola VE, Calandrelli M, Elorriaga N, Gutierrez L, Lanas F, et al. Multiple cardiometabolic risk factors in the southern cone of Latin America: A population-based study in Argentina, Chile, and Uruguay. Int J Cardiol. 2015;183:82-8.
Marquez- Sandoval F, Macedo-Ojeda G, Viramontes-Hörner D, Fernandez Ballart J, Salas Salvado J, Vizmanos B. The pre valence of meta-bolic syndrome in Latin America: a systematic review. Public Health Nutr. 2011;14(10):1702-13.
Juarez XE, Benitez JA, Quezada Galdamez R, Cerritos RW, Aguilar Clara R. Prevalencia del síndrome metabólico en la poblacion urbana de San Salvador. ALAD. 2006;14(1):25-33.
Orozco- Gonzalez CN, Cortes-Sanabria L, Viera-Franco JJ, Ramirez- Marquez JJ, Cueto-Manzano AM. Prevalencia de factores de riesgo car- diovascular en trabajadores de la salud. Rev Med Inst Mex Seguro Soc. 2016;54(5):594-601.
Rivera Portillo TI, Hernandez Campos LY. Prevalencia de síndrome metabólico en los residentes Medicina Interna, Cirugía General y subespecialidades médicas del Hospital Nacional Rosales Año 2016. 2006. Tesis de graduación de Especialista en Medicina Interna Universidad de El Salvador.
Ministerio de Salud/Instituto Nacional de Salud. Encuesta Nacional de Enfermedades Crónicas no Transmisibles en población adulta de El Salvador ENECA-ELS 2015. San Salvador: Ministerio de Salud /Institiuto Nacional de Salud; 2015.
ArroyoJohnson C, Mincey KD. Obesity epidemiology trends by race/ ethnicity, gender, and education: National Health Interview Survey, 1997–2012. Gastroenterol Clin North Am. 2016;45(4):5719.
Dal Canto E, Farukh B, Faconti L. Why are there ethnic differences in cardio-metabolic risk factors and cardiovascular diseases? JRSM Car- diovasc Dis. 2018;12(7):2048004018818923.
Fang J, Shanta M, Cohen H, Aldeman MH. Isolated diastolic hyperten- sion. A favorable finding among young and middle- aged hypertensive subjects. hypertension. 1995;26(3).
The WHO Steps surveillance Manual. [Internet]. Ginebra: Wordl Health Organization; 2017 [citado: 24 mayo 2017]. Disponible en: http://www1.paho.org/hq/dmdocuments/2009/ STEPSmanual.pdf
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Los textos académicos y científicos que se publican en la Revista La Universidad están protegidos bajo la licencia CC BY NC SA 4.0, esta permite usar una obra para crear otra obra o contenido, modificando o no la obra original, siempre que se cite al autor, la obra resultante se comparta bajo el mismo tipo de licencia y no tenga fines comerciales (https://creativecommons.org/licenses/by-nc-sa/4.0/deed.es) . El autor es el único que pose los derechos de publicación y la Revista La Universidad posee los derechos de difusión.
